Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04779879. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Parallel Group Phase II Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Second Generation VIR-7831 Material in Non-Hospitalized Participants With Mild to Moderate Coronavirus Disease 2019 (COVID-19)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2 study in which subjects with coronavirus disease 2019 (COVID-19) will receive VIR-7831 (Sotrovimab) Generation 1 (Gen1) or VIR-7831 (Sotrovimab) Generation 2 (Gen2) and will be assessed for safety, tolerability, and pharmacokinetics.
Study identification
- NCT ID
- NCT04779879
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 354 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 69 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 18, 2021 (Actual)
- Primary completion
- Aug 20, 2021 (Actual)
- Completion
- Apr 6, 2022 (Actual)
- Last update posted
- May 3, 2023
2021 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 8
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site | Anniston | Alabama | 36207 | — |
| Investigative Site | Bakersfield | California | 93301 | — |
| Investigative Site | Northridge | California | 91325 | — |
| Investigative Site | Ft. Pierce | Florida | 34982 | — |
| Investigative Site | Gainesville | Florida | 32607 | — |
| Investigative Site | Hialeah | Florida | 33016 | — |
| Investigative Site | Miami | Florida | 33125 | — |
| Investigative Site | Miami | Florida | 33135 | — |
| Investigative Site | Miami | Florida | 33155 | — |
| Investigative Site | Miami | Florida | 33176 | — |
| Investigative Site | Orlando | Florida | 32803 | — |
| Investigative Site | Pembroke Pines | Florida | 33024 | — |
| Investigative Site | Tampa | Florida | 33614 | — |
| Investigative Site | Columbus | Georgia | 31904 | — |
| Investigative Site | Winfield | Illinois | 60190 | — |
| Investigative Site | Rockville | Maryland | 20850 | — |
| Investigative Site | The Bronx | New York | 10456 | — |
| Investigative Site | Houston | Texas | 77090 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04779879, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2023 · Synced Nov 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.